Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | DHC Continus 120mg tablets (Napp Pharmaceuticals Ltd) |
| BNF code | 0407020G0BBACAF |
| Virtual Medicinal Product | Dihydrocodeine 120mg modified-release tablets |
| Name | DHC Continus 120mg tablets |
| Date of name applicability | 11 Dec 2003 |
| Previous name | DHC Continus 120mg tablets |
| Supplier | Napp Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Excipients | |
|---|---|
| Ingredient | Cetostearyl alcohol |
| Excipients | |
| Ingredient | Lactose |
| Licensed Route | |
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| DHC Continus 120mg tablets (Napp Pharmaceuticals Ltd) 56 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_1.3.0_20220124000001, imported on 25th January 2022 at 04:13:55.